KAREN CHEN: Open Payments
NPI 1366112567 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 66 payments from 21 companies in 2025. Trend: 2023 $309 · 2024 $534 · 2025 $2,026
Food & beverage: $1,949Education: $77
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $397 |
| ABBVIE INC. | 13 | $329 |
| PFIZER INC. | 12 | $225 |
| Alexion Pharmaceuticals, Inc. | 6 | $207 |
| Neurelis, Inc. | 2 | $136 |
| LivaNova USA, Inc. | 1 | $104 |
| Janssen Biotech, Inc. | 2 | $102 |
| Lundbeck LLC | 4 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Corium, LLC | 2 | $54 |
Products named: QULIPTA, ARISTADA, NURTEC ODT, VALTOCO, REXULTI, VIVITROL, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, ULTOMIRIS.
Industry payments across PA — which companies pay providers there.
